| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.003 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.098 | 0.004 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.004 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.13 | 0.005 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.005 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.098 | 0.005 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.008 |